1. Home
  2. ZETA vs FOLD Comparison

ZETA vs FOLD Comparison

Compare ZETA & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zeta Global Holdings Corp.

ZETA

Zeta Global Holdings Corp.

HOLD

Current Price

$18.63

Market Cap

4.3B

Sector

Technology

ML Signal

HOLD

Logo Amicus Therapeutics Inc.

FOLD

Amicus Therapeutics Inc.

HOLD

Current Price

$14.49

Market Cap

4.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZETA
FOLD
Founded
2007
2002
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3B
4.5B
IPO Year
2021
2006

Fundamental Metrics

Financial Performance
Metric
ZETA
FOLD
Price
$18.63
$14.49
Analyst Decision
Strong Buy
Buy
Analyst Count
12
9
Target Price
$27.67
$27.25
AVG Volume (30 Days)
7.7M
2.5M
Earning Date
04-30-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
63.16
50.00
EPS
N/A
N/A
Revenue
$1,304,668,000.00
N/A
Revenue This Year
$37.35
$20.50
Revenue Next Year
$16.29
$18.59
P/E Ratio
N/A
N/A
Revenue Growth
29.72
N/A
52 Week Low
$12.10
$5.66
52 Week High
$24.90
$14.50

Technical Indicators

Market Signals
Indicator
ZETA
FOLD
Relative Strength Index (RSI) 57.68 74.18
Support Level $17.50 $14.21
Resistance Level $19.83 N/A
Average True Range (ATR) 0.92 0.02
MACD 0.12 -0.00
Stochastic Oscillator 71.77 100.00

Price Performance

Historical Comparison
ZETA
FOLD

About ZETA Zeta Global Holdings Corp.

Zeta Global Holdings Corp is an omnichannel data-driven cloud platform that provides enterprises with consumer intelligence and marketing automation software. It serves enterprise customers across multiple industries, including financial services, insurance, telecommunications, automotive, travel and hospitality, and retail. Its Zeta Marketing Platform, or ZMP, is an omnichannel marketing platform with identity data at its core. The ZMP can analyze billions of structured and unstructured data points to predict consumer intent by leveraging sophisticated machine learning algorithms and the industry's opted-in data set for omnichannel marketing. The company operates in U.S, where it generates maximum revenue and Internationally as well.

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a biotechnology company focused to develop and deliver transformative medicines for people living with rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

Share on Social Networks: